Welcome to Pink Sheet
Create an account to read this article
Already a subscriber?
HHS/FDA open Indian offices
Health and Human Services Secretary Mike Leavitt and FDA Commissioner Andrew von Eschenbach announce Jan. 15 the agencies have offices established in New Delhi, and Mumbai, India. Ten HHS/FDA officials will be assigned in India "to work closely with industries that ship food and medical products to the United States, to improve safety and quality, which will facilitate the smooth flow of trade," HHS says. FDA also has a presence in China, Central America and Europe. As part of its Beyond Our Borders Initiative, the agency says it will expand in 2009 to Mexico, the Middle East and South America and open additional European sites (1"The Tan Sheet" Jan. 28, 2008, p. 3)
More from Archive
• By
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
• By
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
• By
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
• By
A new pilot aims to take Brazil closer to ‘digital transformation.’
More from Pink Sheet
• By
A newly launched UK government inquiry is seeking to learn how viable it would be to bring back domestic control over the entire drug manufacturing pipeline.
Sponsored by:
Learn how advances in vaccine adjuvants are shaping the future of global health and driving more effective immunization strategies
• By
Sean Keveney is largely unknown in the FDA law space, but likely is familiar and connected to the White House given his work on Trump’s antisemitism taskforce.